Alvotech (NASDAQ: ALVO), a global biotech specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that members of the leadership team will participate in the Jefferies London Healthcare Conference from November 15th to November 17th.
Visit link:
Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November
Recommendation and review posted by Fredricko
